INS and diabetes mellitus: It is possible that children with chromosomal anomalies may have an increased risk of requiring insulin therapy given the genetic origins of monogenic diabetes, but given the rarity of monogenic diabetes, affecting 1–4% of childhood diabetes, it is unlikely that this will have affected our results on children with chromosomal anomalies.